VAUD : Mymetics and Baylor College of Medicine start Research Collaboration for Virosome-based Covid-19 Vaccines

VAUD : Mymetics and Baylor College of Medicine start Research Collaboration for Virosome-based Covid-19 Vaccines

Mymetics has started a Covid-19 vaccine development project based on Mymetics’ virosome vaccine carrier platform, which will evaluate different rationally designed SARS-CoV-2 antigens for an effective and safe virosomebased Covid-19 vaccine. Baylor College of Medicine in Texas has developed SARS-CoV and SARS-CoV-2 recombinant proteins and has extensive expertise developing protein-based vaccines from discovery through clinical testing. Baylor and Mymetics will collaborate to evaluate the Baylor SARS recombinant protein antigens linked to Mymetics’ virosomes in preclinical studies with the aim to identify and select the most efficacious and safe formulations to take forward a virosome-based COVID-19 vaccine through product and clinical development

MORE

Leave a reply